Skip to main content
. 2011 Dec 6;16(12):1752–1761. doi: 10.1634/theoncologist.2011-0029

Figure 2.

Figure 2.

Expected net gain (ENG) for the options to delay and trial (ENGDT) and adopt and trial (ENGAT) for different sample sizes. The gray dotted line marks the optimal sample size (highest expected net gain). Abbreviations: ENG, expected net gain; ENGDT, ENG for the options to delay and trial; ENGAT, ENG for the options to adopt and trial.